Sernova Corp. $435.182M Market Capitaliztion Sernova Corp. (SVA.V) has provided a progress update on the Company’s Phase 1/2 type 1 diabetes (T1D) clinical trial in conjunction with Dr. Piotr…
Search Results for: sva.v
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP….
Forget-Me-Not Whether you believe in the metaphysical or not, there’s no denying the achievements of science. In particular, biotechnology has uncovered significant advancements in the field of medicine. For context,…
“A once-a-day pill that reduces HbA1c and improves time in range with continuous glucose monitoring, without increasing hypoglycemia or any signal for adverse events, is a big win for…